IL9 and type 1 diabetes mellitus: We aimed to assess early angiopathic changes in the long-standing T1D pediatric population and establish their relationship with a wide range of cytokines, chemokines, and growth factor levels, including novel biomarkers such as IL-9 and IL-17.